John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$175M |
| 2 |
Kroger
KR
|
+$148M |
| 3 |
Elevance Health
ELV
|
+$122M |
| 4 |
EA
Electronic Arts
EA
|
+$120M |
| 5 |
Abbott
ABT
|
+$119M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$181M |
| 2 |
Halliburton
HAL
|
+$152M |
| 3 |
Pfizer
PFE
|
+$145M |
| 4 |
AGN
Allergan plc
AGN
|
+$124M |
| 5 |
AutoZone
AZO
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.33% |
| 2 | Technology | 13.07% |
| 3 | Consumer Discretionary | 10.5% |
| 4 | Financials | 9.32% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
PUT
Carter's
CRI
$1.25B
| $639K | ﹤0.01% |
+6,000
| New | +$619K |
|
2077
Camden National
CAC
$956M
| $638K | ﹤0.01% |
22,782
+8,860
| +64% | +$252K |
|
|
CIT
2078
CALL
DELISTED
CIT Group Inc.
CIT
| $638K | ﹤0.01% |
+20,000
| New | +$650K |
|
2079
Seneca Foods Class A
SENEA
$1.29B
| $637K | ﹤0.01% |
17,603
+2,770
| +19% | +$91.5K |
|
|
MRTX
2080
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $637K | ﹤0.01% |
+116,581
| New | +$1.86M |
|
2081
Tootsie Roll Industries
TR
$3.1B
| $636K | ﹤0.01% |
+22,193
| New | +$592K |
|
2082
Sumitomo Mitsui Financial
SMFG
$161B
| $635K | ﹤0.01% |
+110,947
| New | +$678K |
|
2083
CALL
Wynn Resorts
WYNN
$10.1B
| $634K | ﹤0.01% |
7,000
| – | – |
|
|
HCOM
2084
DELISTED
Hawaiian Telcom Holdco, Inc
HCOM
| $633K | ﹤0.01% |
29,853
+8,395
| +39% | +$184K |
|
2085
Vishay Precision Group
VPG
$865M
| $630K | ﹤0.01% |
46,974
-3,200
| -6% | -$44.8K |
|
|
GBL
2086
DELISTED
GAMCO Investors, Inc.
GBL
| $630K | ﹤0.01% |
19,240
-74
| -0.4% | -$2.71K |
|
|
FLIC
2087
DELISTED
First of Long Island Corp
FLIC
| $629K | ﹤0.01% |
+32,922
| New | +$652K |
|
2088
Boise Cascade
BCC
$2.82B
| $628K | ﹤0.01% |
27,365
-169,926
| -86% | -$3.72M |
|
2089
Movado Group
MOV
$802M
| $628K | ﹤0.01% |
+28,978
| New | +$710K |
|
2090
Banc of California
BANC
$2.98B
| $627K | ﹤0.01% |
34,656
-42,228
| -55% | -$811K |
|
2091
Xylem
XYL
$26.7B
| $627K | ﹤0.01% |
14,036
-381,066
| -96% | -$16.6M |
|
2092
CALL
Chord Energy
CHRD
$7.73B
| $626K | ﹤0.01% |
+67,000
| New | +$635K |
|
2093
Cameco
CCJ
$46.7B
| $624K | ﹤0.01% |
56,861
-136,189
| -71% | -$1.62M |
|
|
FBRC
2094
DELISTED
FBR & Co. Common Stock
FBRC
| $624K | ﹤0.01% |
+41,784
| New | +$762K |
|
2095
CALL
PACCAR
PCAR
$68.2B
| $622K | ﹤0.01% |
+18,000
| New | +$662K |
|
|
NE
2096
CALL
DELISTED
Noble Corporation
NE
| $620K | ﹤0.01% |
+75,200
| New | +$717K |
|
|
NE
2097
PUT
DELISTED
Noble Corporation
NE
| $620K | ﹤0.01% |
+75,200
| New | +$717K |
|
2098
PUT
Citizens Financial Group
CFG
$29.7B
| $619K | ﹤0.01% |
31,000
-16,600
| -35% | -$368K |
|
2099
PUT
Canadian Natural Resources
CNQ
$103B
| $617K | ﹤0.01% |
+40,840
| New | +$577K |
|
2100
Rockwell Automation
ROK
$47.8B
| $617K | ﹤0.01% |
+5,375
| New | +$616K |
|
Similar funds
John Overdeck's Q2 2016 Portfolio in Review
As of Q2 2016, John Overdeck held 3,523 positions worth $23.3B, up 11% from $21B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $2B of net new capital in Q2 2016, opening 779 new positions and adding to 1,113 existing holdings. Its largest new stake was Kroger: 4,100,027 shares worth $151M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Pfizer, an estimated $145M trimmed.
- John Overdeck's largest Q2 2016 buy was Kroger: 4,100,027 shares worth $151M.
- John Overdeck added most to Nike in Q2 2016, an estimated $175M increase.
- John Overdeck's biggest Q2 2016 reduction was Pfizer, cutting an estimated $145M.
- John Overdeck fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $181M.
- John Overdeck's ten largest holdings make up 7.4% of its $23.3B portfolio in Q2 2016.
- John Overdeck opened 779 new positions and closed 661 in Q2 2016.
- John Overdeck's portfolio value rose 11% quarter-over-quarter to $23.3B.
Based on Two Sigma Investments's 13F filing for Q2 2016, filed 15 Aug 2016.